Meanwhile, we focused on the correlation between EVA1C expression and abundance of immune infiltrates by immune profiles, and further investigate whether EVA1C could act as a new immune marker for assessing immune microenvironment of glioma patients. Here, EVA1C is linked to central nervous system cancer.